-transparent.png){kind=logo}
Kelfiprim (KP) is a new bactericidal agent containing trimethoprim (T) and sulfametopyrazine (S), a long-acting sulfonamide (ratio 5:4). The posology is one capsule (T 250 mg + S 200 mg) daily, after a loading dose of two capsules on the first day. To evaluate the clinical value of Kelfiprim (KP) vs co-trimoxazole (CO) in urinary tract infection (UTI) a controlled multicenter double-blind trial (MDBT) was carried out in 76 patients suffering from persistent and recurrent UTIs. About 90 per cent response rate (sterile urine at the end of treatment) was obtained for KP and about 85 per cent for CO in recurrent UTI. In persistent UTI the rate of recovery was 66.8 per cent and 53 per cent for KP and CO, respectively. Safety of treatments was excellent in 97 per cent of patients treated with Kelfiprim and 87 per cent treated with co-trimoxazole. Two patients, one in each group, were dropped from the study because of adverse reactions.
G Graziani, and
C Chiarini, and
D Limido, and
A Cantaluppi, and
P Marai, and
G Pincella, and
F Piaia, and
P Zucchelli, and
F Locatelli, and
C Ponticelli
January 1988,
Scandinavian journal of infectious diseases. Supplementum,
G Graziani, and
C Chiarini, and
D Limido, and
A Cantaluppi, and
P Marai, and
G Pincella, and
F Piaia, and
P Zucchelli, and
F Locatelli, and
C Ponticelli
March 1976,
British medical journal,
G Graziani, and
C Chiarini, and
D Limido, and
A Cantaluppi, and
P Marai, and
G Pincella, and
F Piaia, and
P Zucchelli, and
F Locatelli, and
C Ponticelli
February 1982,
Urological research,
G Graziani, and
C Chiarini, and
D Limido, and
A Cantaluppi, and
P Marai, and
G Pincella, and
F Piaia, and
P Zucchelli, and
F Locatelli, and
C Ponticelli
September 1972,
Nederlands tijdschrift voor geneeskunde,
G Graziani, and
C Chiarini, and
D Limido, and
A Cantaluppi, and
P Marai, and
G Pincella, and
F Piaia, and
P Zucchelli, and
F Locatelli, and
C Ponticelli
January 1982,
Infection,
G Graziani, and
C Chiarini, and
D Limido, and
A Cantaluppi, and
P Marai, and
G Pincella, and
F Piaia, and
P Zucchelli, and
F Locatelli, and
C Ponticelli
May 1975,
The Medical journal of Australia,
G Graziani, and
C Chiarini, and
D Limido, and
A Cantaluppi, and
P Marai, and
G Pincella, and
F Piaia, and
P Zucchelli, and
F Locatelli, and
C Ponticelli
July 1973,
Acta urologica Belgica,
G Graziani, and
C Chiarini, and
D Limido, and
A Cantaluppi, and
P Marai, and
G Pincella, and
F Piaia, and
P Zucchelli, and
F Locatelli, and
C Ponticelli
January 1983,
Arzneimittel-Forschung,
G Graziani, and
C Chiarini, and
D Limido, and
A Cantaluppi, and
P Marai, and
G Pincella, and
F Piaia, and
P Zucchelli, and
F Locatelli, and
C Ponticelli
September 1991,
Antimicrobial agents and chemotherapy,
G Graziani, and
C Chiarini, and
D Limido, and
A Cantaluppi, and
P Marai, and
G Pincella, and
F Piaia, and
P Zucchelli, and
F Locatelli, and
C Ponticelli
September 1993,
The Journal of urology,
